ACCESS DAXXIFY
Live / Registered — Registered (as of 05 Aug 2025)
What this means for you
Registered since 05 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98256350
- Registration number
- 7883785
- Mark type
- Stylized text
- Filed
- 06 Nov 2023
- Published for opposition
- 23 Jul 2024
- Registered
- 05 Aug 2025
- Attorney of record
- Jennifer Waitman
Goods and services
- Class 035 — Advertising and business services: Business administration of patient reimbursement programs; Business management of reimbursement programs for others
Owner
- Revance Therapeutics, Inc., Newark, CA, US
- Revance Therapeutics, Inc., Newark, CA, US
- Revance Therapeutics, Inc., Newark, CA, US
Prior registrations
Prosecution history
- 05 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Jul 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jul 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jul 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Jul 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Jun 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Mar 2025 — USE AMENDMENT FILED
- 12 Jun 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Apr 2025 — ASSIGNED TO EXAMINER
- 15 Mar 2025 — TEAS STATEMENT OF USE RECEIVED
- 17 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Jul 2024 — PUBLISHED FOR OPPOSITION